Physician profile
Memory S Smith
NPI 1386168433
$2,319.51
in general payments reported to CMS, 2019-2025
24 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $443 · 2022: $754 · 2023: $354 · 2024: $432 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,122.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $613.94 | 2021-2025 | |
| Nevro Corp. | $347.18 | 2021-2024 | Senza |
| Relievant Medsystems, INC. | $246.74 | 2022 | |
| Stryker Corporation | $163.68 | 2025 | Mild Device Kit |
| Vertos Medical, INC. | $127.40 | 2022-2024 | Mild Device Kit |
| Allergan, INC. | $98.83 | 2021-2022 | |
| Abbott Laboratories | $89.69 | 2021-2024 | Proclaim |
| Spr Therapeutics, INC | $88.42 | 2024-2025 | Sprint Pns System |
| Pfizer INC. | $62.79 | 2021-2023 | |
| Boston Scientific Corporation | $54.07 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $50.52 | 2022 | |
| Globus Medical, INC. | $47.79 | 2025 | Senza |
| Ibsa Pharma INC. | $41.03 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $40.80 | 2022 | |
| Nalu Medical, INC. | $39.99 | 2021-2025 | Nalu Neurostimulation System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $36.38 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Teva Pharmaceuticals USA, INC. | $28.44 | 2022 | |
| Stimwave Technologies Incorporated | $26.14 | 2021-2022 | |
| Amgen INC. | $22.75 | 2022 | |
| Impel Pharmaceuticals INC. | $21.55 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.57 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $18.95 | 2021 | |
| Lilly USA, LLC | $17.23 | 2022 | |
| Convatec INC. | $15.63 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Memory Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.